L-156586

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameL-156586
Drug Alias NameL-156586
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A